Arteriovenous malformations future or investigational therapies

Arteriovenous malformations Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Arteriovenous malformations from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Arteriovenous malformations future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Arteriovenous malformations future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Arteriovenous malformations future or investigational therapies
CDC on Arteriovenous malformations future or investigational therapies
Arteriovenous malformations future or investigational therapies in the news
Blogs on Arteriovenous malformations future or investigational therapies
Directions to Hospitals Treating Arteriovenous malformations
Risk calculators and risk factors for Arteriovenous malformations future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]

Overview

The optimal management of AVMs remains an ongiong topic of clinical research. .